Track: Cancer Pharmacology & Immunology

Sub-Track:

Cancer pharmacology focuses on the study of drugs used in the treatment of cancer. It involves the investigation of drug mechanisms, pharmacokinetics (how drugs are absorbed, distributed, metabolized, and excreted in the body), and pharmacodynamics (how drugs interact with their targets in the body). Cancer pharmacology aims to develop effective and safe therapies that selectively target cancer cells while minimizing damage to healthy tissues. It involves the development of chemotherapy drugs, targeted therapies, immunotherapies, and other anti-cancer agents. Immunology, on the other hand, is the study of the immune system and its role in protecting the body against diseases, including cancer. Cancer immunology focuses specifically on understanding how the immune system recognizes and eliminates cancer cells and how tumors evade immune responses. It investigates the interaction between cancer cells and the immune system, aiming to develop strategies to enhance immune responses against cancer. This includes the development of immunotherapies, such as immune checkpoint inhibitors, CAR-T cell therapy, and cancer vaccines, which harness the body's immune system to target and destroy cancer cells. The fields of cancer pharmacology and immunology are highly intertwined. Pharmacological approaches often involve the use of immunotherapies or immunomodulatory drugs to enhance the immune response against cancer. Additionally, understanding the pharmacology of anti-cancer drugs is essential for optimizing their efficacy and minimizing toxicity. The development of targeted therapies and immunotherapies has revolutionized cancer treatment, leading to improved outcomes and prolonged survival for many patients. Ongoing research in cancer pharmacology and immunology aims to further advance our understanding of the complex interactions between cancer cells and the immune system. This research includes identifying new drug targets, developing more precise and personalized therapies, and overcoming resistance mechanisms. By integrating pharmacological and immunological approaches, researchers strive to improve cancer treatment strategies and ultimately provide better outcomes for patients with cancer.

SUBTOPICS:

· Innovations of Anti Metabolite Drugs

· Alkylating agents

· Microtubule inhibitor

· Miscellaneous agents

· Steroid hormones

· HMT Inhibitors

· Biological Respond Modifier

3RD INTERNATIONAL CONFERENCE ON ONCOLOGY RESEARCH AND TREATMENT

NOVEMBER 30-DECEMBER 01, 2023 | Dubai - United Arab Emirates

Track: Cancer Pharmacology & Immunology

Sub-Track:

Scientific Highlights

Organization Location

Mail us at

Our Social Presence

Call us at